Target Name: GRIP1
NCBI ID: G23426
Review Report on GRIP1 Target / Biomarker Content of Review Report on GRIP1 Target / Biomarker
GRIP1
Other Name(s): GRIP1 variant 1 | OTTHUMP00000239969 | Glutamate receptor-interacting protein 1 (isoform 2) | Glutamate receptor-interacting protein 1 (isoform 1) | OTTHUMP00000239945 | OTTHUMP00000239944 | glutamate receptor interacting protein 1 | Glutamate receptor interacting protein 1, transcript variant 1 | Glutamate receptor-interacting protein 1 | FRASRS3 | GRIP | OTTHUMP00000239946 | OTTHUMP00000239947 | Glutamate receptor interacting protein 1, transcript variant 2 | GRIP1_HUMAN | GRIP1 variant 2 | GRIP-1

GRIP1: A Potential Drug Target for Pain and Inflammation

GRIP1 (G protein-coupled receptor 1) is a protein that is expressed in many different tissues throughout the body, including the brain, lungs, heart, kidneys, and intestines. It is a member of the G protein-coupled receptor family, which is a large family of transmembrane proteins that play a key role in cellular signaling.

GRIP1 is involved in many different signaling pathways, including the regulation of pain, inflammation, and cell survival. It is also involved in the regulation of body temperature and in the regulation of the blood pressure.

GRIP1 has been identified as a potential drug target due to its involvement in multiple signaling pathways. It is a good candidate for inhibition due to its role in pain perception and inflammation.

GRIP1 has been shown to play a key role in pain perception. When the body experiences pain, GRIP1 is involved in the transmission of pain signals from the damaged tissue to the brain. It is thought to do this by modulating the activity of other pain-related genes, such as TrkA and TrkB.

In addition to its role in pain perception, GRIP1 is also involved in the regulation of inflammation. When the body is exposed to an infection, GRIP1 is involved in the regulation of the immune response and the production of pro-inflammatory cytokines.

GRIP1 is also involved in the regulation of cell survival. When the body is exposed to stress or other forms of damage, GRIP1 is involved in the regulation of cell death and the survival of cells.

GRIP1 has also been shown to play a role in the regulation of body temperature. When the body is exposed to heat or cold, GRIP1 is involved in the regulation of sweat glands and vasodilation to control body temperature.

GRIP1 has been identified as a potential drug target due to its involvement in multiple signaling pathways. It is a good candidate for inhibition due to its role in pain perception and inflammation.

In conclusion, GRIP1 is a protein that is involved in many different signaling pathways in the body. It is a potential drug target due to its role in pain perception and inflammation. Further research is needed to fully understand the role of GRIP1 in the regulation of pain and inflammation.

Protein Name: Glutamate Receptor Interacting Protein 1

Functions: May play a role as a localized scaffold for the assembly of a multiprotein signaling complex and as mediator of the trafficking of its binding partners at specific subcellular location in neurons (PubMed:10197531). Through complex formation with NSG1, GRIA2 and STX12 controls the intracellular fate of AMPAR and the endosomal sorting of the GRIA2 subunit toward recycling and membrane targeting (By similarity)

The "GRIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GRIP2 | GRIPAP1 | GRK1 | GRK2 | GRK3 | GRK4 | GRK5 | GRK6 | GRK7 | GRM1 | GRM2 | GRM3 | GRM4 | GRM5 | GRM5-AS1 | GRM5P1 | GRM6 | GRM7 | GRM7-AS3 | GRM8 | GRM8-AS1 | GRN | Growth Factor Receptor-Bound Protein | GRP | GRPEL1 | GRPEL2 | GRPEL2-AS1 | GRPR | GRSF1 | GRTP1 | GRTP1-AS1 | GRWD1 | GRXCR1 | GRXCR2 | GS1-24F4.2 | GS1-600G8.3 | GSAP | GSC | GSC2 | GSDMA | GSDMB | GSDMC | GSDMD | GSDME | GSE1 | GSEC | GSG1 | GSG1L | GSG1L2 | GSK3A | GSK3B | GSKIP | GSN | GSPT1 | GSPT2 | GSR | GSS | GSTA1 | GSTA12P | GSTA2 | GSTA3 | GSTA4 | GSTA5 | GSTA7P | GSTCD | GSTK1 | GSTM1 | GSTM2 | GSTM2P1 | GSTM3 | GSTM4 | GSTM5 | GSTM5P1 | GSTO1 | GSTO2 | GSTP1 | GSTT1 | GSTT2 | GSTT2B | GSTT4 | GSTTP2 | GSTZ1 | GSX1 | GSX2 | GTDC1 | GTF2A1 | GTF2A1L | GTF2A2 | GTF2B | GTF2E1 | GTF2E2 | GTF2F1 | GTF2F2 | GTF2H1 | GTF2H2 | GTF2H2B | GTF2H2C | GTF2H2C_2 | GTF2H3 | GTF2H4